Search Results - Ruilian Wu
- Showing 1 - 3 results of 3
-
1
-
2
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of... by Ryan Choi, Mowei Zhou, Roger Shek, Jesse W Wilson, Logan Tillery, Justin K Craig, Indraneel A Salukhe, Sarah E Hickson, Neeraj Kumar, Rhema M James, Garry W Buchko, Ruilian Wu, Sydney Huff, Tu-Trinh Nguyen, Brett L Hurst, Sara Cherry, Lynn K Barrett, Jennifer L Hyde, Wesley C Van Voorhis
Published in PLoS ONE (2021-01-01)Get full text
Article -
3
Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase. by Heung-Bok Kim, John-Paul Bacik, Ruilian Wu, Ramesh K Jha, Michaeline Hebron, Catherine Triandafillou, Joseph E McCown, Nam-In Baek, Jeong Han Kim, Young Jae Kim, Celia W Goulding, Charlie E M Strauss, Jurgen G Schmidt, Gauri S Shetye, Sungweon Ryoo, Eun-Kyeong Jo, Young Ho Jeon, Li-Wei Hung, Thomas C Terwilliger, Chang-Yub Kim
Published in PLoS ONE (2022-01-01)Get full text
Article
